Brief: Egetis Therapeutics Carries Out Directed Share Issue Of SEK 210 Million

Egetis Therapeutics AB (publ)

25/01/2023 07:18

Jan 25 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * HAS SUCCESSFULLY CARRIED OUT A DIRECTED SHARE ISSUE
AMOUNTING TO
SEK 210 MILLION
    * DIRECTED ISSUE ENTAILS A DILUTION OF ABOUT 14.0 PERCENT OF
THE
NUMBER OF SHARES AND VOTES IN THE COMPANY
    * SUBSCRIPTION PRICE OF SEK 6.00 PER SHARE
    * DIRECTED ISSUE WAS OVERSUBSCRIBED

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nMFNc7CJJW
 Further company coverage:  EGTX.ST  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))